Imre Noth, MD

Professor of Medicine

Director, Interstitial Lung Disease Program

Dr. Imre Noth is a pulmonologist specializing in interstitial lung diseases (pulmonary fibrosis). In his practice, he sees patients in clinic as well as in the intensive care unit. Dr. Noth sees a wide variety of pulmonary patients ranging from emphysema to asthma and interstitial lung disease. Over the last half decade, he has concentrated his efforts on interstitial lung diseases with a special emphasis on idiopathic pulmonary fibrosis (IPF). This has allowed him to focus on the unique needs of this patient population.

Dr. Noth has participated--and continues to participate--as principal investigator in numerous clinical trials that focus predominantly on IPF but also on severe asthma, and chronic obstructive pulmonary diseases (COPD). These have led to recognition in the field for his expertise. His recent research includes studying the relationship between genetics, genomics and outcomes in IPF, as well as in the conduct of novel clinical trials in IPF. Dr. Noth is also a member of the National Institutes of Health sponsored IPF clinical research network. Through the ILD program, he hopes to continue to conduct research that will allow a better understanding of the natural history of interstitial lung diseases and develop better approaches to therapy.

In addition to authoring several book chapters on critical care medicine, Dr. Noth is a reviewer for the American Journal of Respiratory and Critical Care Medicine and the Journal of Respiratory Diseases. He also sits on the editorial board for Chest.